ANAPLASTIC LARGE CELL LYMPHOMA
Clinical trials for ANAPLASTIC LARGE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC LARGE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC LARGE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant strategy offers hope for tough blood cancers
Disease control Recruiting nowThis study is testing a stem cell transplant from a partially matched family donor for patients with hard-to-treat blood cancers like leukemia and lymphoma. Before the transplant, patients receive chemotherapy and radiation to wipe out their own bone marrow and cancer cells. The …
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Gene therapy trial aims to turn Patients' own cells against rare, aggressive cancers
Disease control Recruiting nowThis early-stage trial is testing the safety of a new gene therapy for adults with certain T-cell lymphomas that have returned or not responded to prior treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to target a protein (CCR4) foun…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Repurposing a cancer drug to fight rare tumors
Disease control Recruiting nowThis trial is testing if a drug called alectinib, already approved for a type of lung cancer, can help treat other rare cancers that share the same genetic change (ALK mutation). It will involve about 30 adults and children with various rare or hard-to-treat cancers. The goal is …
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Doctors test Cancer-Killing virus in patients who have run out of options
Disease control Recruiting nowThis early-phase study is testing a new treatment approach for patients with T-cell lymphoma that has returned or stopped responding to standard therapies. Researchers are combining a genetically modified virus designed to attack cancer cells with two immunotherapy drugs that hel…
Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC